BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tao R, Hu S, Wang S, Zhou X, Zhang Q, Wang C, Zhao X, Zhou W, Zhang S, Li C, Zhao H, He Y, Zhu S, Xu J, Jiang Y, Li L, Gao Y. Association between indel polymorphism in the promoter region of lncRNA GAS5 and the risk of hepatocellular carcinoma. Carcinogenesis 2015;36:1136-43. [PMID: 26163879 DOI: 10.1093/carcin/bgv099] [Cited by in Crossref: 71] [Cited by in F6Publishing: 84] [Article Influence: 10.1] [Reference Citation Analysis]
Number Citing Articles
1 Lyu Y, Yang S, Lyu X, Wang YL, Ji S, Kang S, Jiang Y, Xiang J, He C, Li P, Liu B, Wu C. lncRNA polymorphism affects the prognosis of gastric cancer. World J Surg Oncol 2022;20:273. [PMID: 36045445 DOI: 10.1186/s12957-022-02723-x] [Reference Citation Analysis]
2 Li Y, Sun C, Guo Y, Qiu S, Li Y, Liu Y, Zhong W, Wang H, Cheng Y, Liu Y. DIP2C polymorphisms are implicated in susceptibility and clinical phenotypes of autism spectrum disorder. Psychiatry Res 2022;316:114792. [PMID: 35987071 DOI: 10.1016/j.psychres.2022.114792] [Reference Citation Analysis]
3 Xu S, Wang Y, Li Z, Hua Q, Jiang M, Fan X. LncRNA GAS5 Knockdown Mitigates Hepatic Lipid Accumulation via Regulating MiR-26a-5p/PDE4B to Activate cAMP/CREB Pathway. Front Endocrinol 2022;13:889858. [DOI: 10.3389/fendo.2022.889858] [Reference Citation Analysis]
4 Li HC, Yang CH, Lo SY. Long noncoding RNAs in hepatitis B virus replication and oncogenesis. World J Gastroenterol 2022; 28(25): 2823-2842 [DOI: 10.3748/wjg.v28.i25.2823] [Reference Citation Analysis]
5 Ji Y, Yang Y, Yin Z. Polymorphisms in lncRNA CCAT1 on the susceptibility of lung cancer in a Chinese northeast population: A case–control study. Cancer Medicine. [DOI: 10.1002/cam4.4902] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kaur J, Salehen N, Norazit A, Rahman AA, Murad NAA, Rahman NMANA, Ibrahim K. Tumor Suppressive Effects of GAS5 in Cancer Cells. ncRNA 2022;8:39. [DOI: 10.3390/ncrna8030039] [Reference Citation Analysis]
7 Xiang X, Chen L, He J, Ma G, Li Y. LncRNA GAS5 rs145204276 Polymorphism Reduces Renal Cell Carcinoma Susceptibility in Southern Chinese Population. JIR 2022;Volume 15:1147-58. [DOI: 10.2147/jir.s348628] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Liu YL, Hu XL, Song PY, Li H, Li MP, Du YX, Li MY, Ma QL, Peng LM, Song MY, Chen XP. Influence of GAS5/MicroRNA-223-3p/P2Y12 Axis on Clopidogrel Response in Coronary Artery Disease. J Am Heart Assoc 2021;10:e021129. [PMID: 34713722 DOI: 10.1161/JAHA.121.021129] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Gao G, Liu C, Li X, Guan X, Yang X, Qin P. Growth arrest-specific 5 (GAS5) insertion/deletion polymorphism and cancer susceptibility in Asian populations: A meta-analysis. Medicine (Baltimore) 2021;100:e27415. [PMID: 34731115 DOI: 10.1097/MD.0000000000027415] [Reference Citation Analysis]
10 Zhang WY, Zhan HL, Li MK, Wu GD, Liu Z, Wu LF. Long noncoding RNA Gas5 induces cell apoptosis and inhibits tumor growth via activating the CHOP-dependent endoplasmic reticulum stress pathway in human hepatoblastoma HepG2 cells. J Cell Biochem 2021. [PMID: 34636091 DOI: 10.1002/jcb.30159] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Zhao X, Zhao X, Yin M. Heterogeneous graph attention network based on meta-paths for lncRNA-disease association prediction. Brief Bioinform 2021:bbab407. [PMID: 34585231 DOI: 10.1093/bib/bbab407] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
12 Zhao S, Liu P, Ruan Z, Li J, Zeng S, Zhong M, Tang L. Association between long non-coding RNA (lncRNA) GAS5 polymorphism rs145204276 and cancer risk. J Int Med Res 2021;49:3000605211039798. [PMID: 34521242 DOI: 10.1177/03000605211039798] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Xu D, Wang L, Pang S, Cao M, Wang W, Yu X, Xu Z, Xu J, Wang H, Lu J, Li K. The Functional Characterization of Epigenetically Related lncRNAs Involved in Dysregulated CeRNA-CeRNA Networks Across Eight Cancer Types. Front Cell Dev Biol 2021;9:649755. [PMID: 34222227 DOI: 10.3389/fcell.2021.649755] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
14 Abdelaleem OO, Shaker OG, AbdelHafez MN, Abdelghaffar NK, Eid HM, Zaidan M, Khalefa AA, Ahmed NA, Hemeda NF, Zaki OM, Awaji AAA, Mohammed SR. The Influence of rs1859168 Polymorphism on Serum Expression of HOTTIP and Its Target miR-615-3p in Egyptian Patients with Breast Cancer. Biomolecules 2021;11:733. [PMID: 34069089 DOI: 10.3390/biom11050733] [Reference Citation Analysis]
15 Ghafouri-Fard S, Gholipour M, Hussen BM, Taheri M. The Impact of Long Non-Coding RNAs in the Pathogenesis of Hepatocellular Carcinoma. Front Oncol 2021;11:649107. [PMID: 33968749 DOI: 10.3389/fonc.2021.649107] [Cited by in Crossref: 4] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
16 Deng F, Zhu P, Liao C, Li S, Hu X, Wang Y, Wu Z, Huang S, Zhong W, Zhao B, Ma G, Li Y. Genetic Variants of lncRNA GAS5 Contribute to Susceptibility of Ischemic Stroke among Southern Chinese Population. Biomed Res Int 2021;2021:6634253. [PMID: 33937403 DOI: 10.1155/2021/6634253] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Li Q, Fu L, Han L, Li S, Zhang Y, Wang J. Long Noncoding RNA GAS5 Accelerates Cholangiocarcinoma Progression by Regulating hsa-miR-1297. Cancer Manag Res 2021;13:2745-53. [PMID: 33790648 DOI: 10.2147/CMAR.S297868] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
18 Liu CH, Lu YL, Huang HT, Wang CF, Luo HC, Wei GJ, Lei M, Tan T, Wang Y, Huang YY, Wei YS, Lan Y. Association of LncRNA-GAS5 gene polymorphisms and PBMC LncRNA-GAS5 level with risk of systemic lupus erythematosus in Chinese population. J Cell Mol Med 2021;25:3548-59. [PMID: 33728802 DOI: 10.1111/jcmm.16438] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Xiao ZS, Zhao L, Zhang XN, Li HX, Yin ZH. Effect of rs67085638 in long non-coding RNA (CCAT1) on colon cancer chemoresistance to paclitaxel through modulating the microRNA-24-3p and FSCN1. J Cell Mol Med 2021;25:3744-53. [PMID: 33709519 DOI: 10.1111/jcmm.16210] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Abdi E, Latifi-navid S, Latifi-navid H, Safaralizadeh R. LncRNA polymorphisms and upper gastrointestinal cancer risk. Pathology - Research and Practice 2021;218:153324. [DOI: 10.1016/j.prp.2020.153324] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
21 Poursheikhani A, Nokhandani N, Yousefi H, Rad DM, Sahebkar A. Clinicopathological Significance of Long Non-Coding RNA GHET1 in Human Cancers: A Meta-Analysis. CPB 2020;21:1422-32. [DOI: 10.2174/1389201021999200727163238] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
22 Sharifi R, Shahangian SS, Salehi Z, Mashayekhi F, Talesh Sasani S, Mirzanezhad L. Influence of a 5-bp Indel Polymorphism at Promoter of the GAS5 lncRNA and Risk of Breast Cancer. Asian Pac J Cancer Prev 2020;21:3705-10. [PMID: 33369471 DOI: 10.31557/APJCP.2020.21.12.3705] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
23 Rinaldetti S, Worst TS, Rempel E, Kriegmair MC, Hartmann A, Porubsky S, Bolenz C, Erben P. Subtype specific expression and survival prediction of pivotal lncRNAs in muscle invasive bladder cancer. Sci Rep 2020;10:20472. [PMID: 33235218 DOI: 10.1038/s41598-020-77252-2] [Reference Citation Analysis]
24 Deng ZH, Yu GS, Pan B, Feng ZH, Huang Q, Deng JZ, Chen B, Yang SK. Rs145204276 and rs4759314 affect the prognosis of prostate cancer by modulating the GAS5/miR-1284/HMGB1 and HOTAIR/miR-22/HMGB1 signalling pathways. Artif Cells Nanomed Biotechnol 2020;48:435-42. [PMID: 31916466 DOI: 10.1080/21691401.2019.1709859] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
25 Cai H, Xu W, Zhang X. LncRNA growth arrest-special 5 polymorphisms and predisposition to cancer: A meta-analysis. Int J Biol Markers 2020;35:28-34. [PMID: 32996361 DOI: 10.1177/1724600820915483] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Mahpour A, Mullen AC. Our emerging understanding of the roles of long non-coding RNAs in normal liver function, disease, and malignancy. JHEP Rep 2021;3:100177. [PMID: 33294829 DOI: 10.1016/j.jhepr.2020.100177] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
27 Elsayed AM, Amero P, Salama SA, Abdelaziz AH, Lopez-Berestein G, Rodriguez-Aguayo C. Back to the Future: Rethinking the Great Potential of lncRNAS for Optimizing Chemotherapeutic Response in Ovarian Cancer. Cancers (Basel) 2020;12:E2406. [PMID: 32854207 DOI: 10.3390/cancers12092406] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
28 Yang X, Xie Z, Lei X, Gan R. Long non-coding RNA GAS5 in human cancer. Oncol Lett 2020;20:2587-94. [PMID: 32782576 DOI: 10.3892/ol.2020.11809] [Cited by in Crossref: 16] [Cited by in F6Publishing: 32] [Article Influence: 8.0] [Reference Citation Analysis]
29 Li Y, He HC, Zhou DL, Liu Q, Zhang X, Yang XH, Ye ZL, Peng JL, Tang T, Su X, He CY. Associations between lncRNA-related polymorphisms and hepatocellular carcinoma risk: A two-stage case-control study. J Gastroenterol Hepatol 2021;36:233-9. [PMID: 32453900 DOI: 10.1111/jgh.15118] [Reference Citation Analysis]
30 Xu W, Zhang L, Geng Y, Liu Y, Zhang N. Long noncoding RNA GAS5 promotes microglial inflammatory response in Parkinson's disease by regulating NLRP3 pathway through sponging miR-223-3p. Int Immunopharmacol 2020;85:106614. [PMID: 32470877 DOI: 10.1016/j.intimp.2020.106614] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
31 Zou H, Wu LX, Tan L, Shang FF, Zhou HH. Significance of Single-Nucleotide Variants in Long Intergenic Non-protein Coding RNAs. Front Cell Dev Biol 2020;8:347. [PMID: 32523949 DOI: 10.3389/fcell.2020.00347] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
32 Weng SL, Ng SC, Lee YC, Hsiao YH, Hsu CF, Yang SF, Wang PH. The relationships of genetic polymorphisms of the long noncoding RNA growth arrest-specific transcript 5 with uterine cervical cancer. Int J Med Sci 2020;17:1187-95. [PMID: 32547314 DOI: 10.7150/ijms.44583] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
33 Weng WC, Chen CJ, Chen PN, Wang SS, Hsieh MJ, Yang SF. Impact of Gene Polymorphisms in GAS5 on Urothelial Cell Carcinoma Development and Clinical Characteristics. Diagnostics (Basel) 2020;10:E260. [PMID: 32354045 DOI: 10.3390/diagnostics10050260] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
34 Li W, Jiang X, Jin X, Yan W, Liu Y, Li D, Zhao Z. Significant association between long non-coding RNA H19 polymorphisms and cancer susceptibility: A PRISMA-compliant meta-analysis and bioinformatics prediction. Medicine (Baltimore) 2020;99:e19322. [PMID: 32282694 DOI: 10.1097/MD.0000000000019322] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
35 Dong X, Gao W, Lv X, Wang Y, Wu Q, Yang Z, Mao G, Xing W. Association between lncRNA GAS5, MEG3, and PCAT-1 Polymorphisms and Cancer Risk: A Meta-Analysis. Dis Markers 2020;2020:6723487. [PMID: 32300378 DOI: 10.1155/2020/6723487] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
36 Ding Y, Sun Z, Zhang S, Chen Y, Zhou B, Li G, Sun Q, Zhou D, Ge Y, Yan S, Wang W. Down-regulation of Long Non-coding RNA LINC01554 in Hepatocellular Cancer and its Clinical Significance. J Cancer 2020;11:3369-74. [PMID: 32231743 DOI: 10.7150/jca.40512] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
37 Fang P, Xiang L, Chen W, Li S, Huang S, Li J, Zhuge L, Jin L, Feng W, Chen Y, Pan C. LncRNA GAS5 enhanced the killing effect of NK cell on liver cancer through regulating miR-544/RUNX3. Innate Immun 2019;25:99-109. [PMID: 30774011 DOI: 10.1177/1753425919827632] [Cited by in Crossref: 28] [Cited by in F6Publishing: 47] [Article Influence: 14.0] [Reference Citation Analysis]
38 Ketab FNG, Gharesouran J, Ghafouri-Fard S, Dastar S, Mazraeh SA, Hosseinzadeh H, Moradi M, Javadlar M, Hiradfar A, Rezamand A, Taheri M, Rezazadeh M. Dual biomarkers long non-coding RNA GAS5 and its target, NR3C1, contribute to acute myeloid leukemia. Exp Mol Pathol 2020;114:104399. [PMID: 32032633 DOI: 10.1016/j.yexmp.2020.104399] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
39 Dai J, Huang M, Amos CI, Hung RJ, Tardon A, Andrew A, Chen C, Christiani DC, Albanes D, Rennert G, Fan J, Goodman G, Liu G, Field JK, Grankvist K, Kiemeney LA, Le Marchand L, Schabath MB, Johansson M, Aldrich MC, Johansson M, Caporaso N, Lazarus P, Lam S, Bojesen SE, Arnold S, Landi MT, Risch A, Wichmann HE, Bickeboller H, Brennan P, Shete S, Melander O, Brunnstrom H, Zienolddiny S, Woll P, Stevens V, Hu Z, Shen H. Genome-wide association study of INDELs identified four novel susceptibility loci associated with lung cancer risk. Int J Cancer 2020;146:2855-64. [PMID: 31577861 DOI: 10.1002/ijc.32698] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
40 Huang MC, Chou YH, Shen HP, Ng SC, Lee YC, Sun YH, Hsu CF, Yang SF, Wang PH. The clinicopathological characteristic associations of long non-coding RNA gene H19 polymorphisms with uterine cervical cancer. J Cancer 2019;10:6191-8. [PMID: 31772651 DOI: 10.7150/jca.36707] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
41 Lin CY, Wang SS, Yang CK, Li JR, Chen CS, Hung SC, Chiu KY, Cheng CL, Ou YC, Yang SF. Impact of GAS5 genetic polymorphism on prostate cancer susceptibility and clinicopathologic characteristics. Int J Med Sci 2019;16:1424-9. [PMID: 31673232 DOI: 10.7150/ijms.38080] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
42 Long X, Song K, Hu H, Tian Q, Wang W, Dong Q, Yin X, Di W. Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis. J Exp Clin Cancer Res 2019;38:345. [PMID: 31391118 DOI: 10.1186/s13046-019-1329-2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 67] [Article Influence: 14.7] [Reference Citation Analysis]
43 Sherpa C, Rausch JW, Le Grice SF. Structural characterization of maternally expressed gene 3 RNA reveals conserved motifs and potential sites of interaction with polycomb repressive complex 2. Nucleic Acids Res. 2018;46:10432-10447. [PMID: 30102382 DOI: 10.1093/nar/gky722] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 8.7] [Reference Citation Analysis]
44 Yang W, Xu X, Hong L, Wang Q, Huang J, Jiang L. Upregulation of lncRNA GAS5 inhibits the growth and metastasis of cervical cancer cells. J Cell Physiol 2019;234:23571-80. [PMID: 31206689 DOI: 10.1002/jcp.28926] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 8.7] [Reference Citation Analysis]
45 Mai H, Zhou B, Liu L, Yang F, Conran C, Ji Y, Hou J, Jiang D. Molecular pattern of lncRNAs in hepatocellular carcinoma. J Exp Clin Cancer Res 2019;38:198. [PMID: 31097003 DOI: 10.1186/s13046-019-1213-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 31] [Article Influence: 7.0] [Reference Citation Analysis]
46 Wang Y, Wu S, Yang X, Li X, Chen R. Association between polymorphism in the promoter region of lncRNA GAS5 and the risk of colorectal cancer. Biosci Rep 2019;39:BSR20190091. [PMID: 30902880 DOI: 10.1042/BSR20190091] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
47 Ghaforui-Fard S, Taheri M. Growth arrest specific transcript 5 in tumorigenesis process: An update on the expression pattern and genomic variants. Biomed Pharmacother 2019;112:108723. [PMID: 30970522 DOI: 10.1016/j.biopha.2019.108723] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 4.7] [Reference Citation Analysis]
48 Li MK, Zhan HL, Wu LF. Progress in research of long non-coding RNA GAS5 in human tumors. Shijie Huaren Xiaohua Zazhi 2019; 27(3): 175-182 [DOI: 10.11569/wcjd.v27.i3.175] [Reference Citation Analysis]
49 Zeng Y, Li TL, Zhang HB, Deng JL, Zhang R, Sun H, Wan ZR, Liu YZ, Zhu YS, Wang G. Polymorphisms in IGF2/H19 gene locus are associated with platinum-based chemotherapeutic response in Chinese patients with epithelial ovarian cancer. Pharmacogenomics 2019;20:179-88. [PMID: 30672383 DOI: 10.2217/pgs-2018-0153] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
50 Lu S, Su Z, Fu W, Cui Z, Jiang X, Tai S. Altered expression of long non-coding RNA GAS5 in digestive tumors. Biosci Rep 2019;39:BSR20180789. [PMID: 30606744 DOI: 10.1042/BSR20180789] [Cited by in Crossref: 17] [Cited by in F6Publishing: 25] [Article Influence: 5.7] [Reference Citation Analysis]
51 Xiang W, Li Z, Lin Z, You K, Pan M, Zheng G. Association between indel polymorphism (rs145204276) in the promoter region of lncRNA GAS5 and the risk of febrile convulsion. J Cell Physiol 2019. [PMID: 30656683 DOI: 10.1002/jcp.28158] [Reference Citation Analysis]
52 Xie G, Huang Z, Liu Z, Lin Z, Ma L. NCPHLDA: a novel method for human lncRNA–disease association prediction based on network consistency projection. Mol Omics 2019;15:442-50. [DOI: 10.1039/c9mo00092e] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
53 Zhu Q, Yang H, Cheng P, Han Q. Bioinformatic analysis of the prognostic value of the lncRNAs encoding snoRNAs in hepatocellular carcinoma. Biofactors 2019;45:244-52. [PMID: 30537372 DOI: 10.1002/biof.1478] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
54 Hashemi M, Moazeni-roodi A, Tabasi F, Ghavami S. 5-bp insertion/deletion polymorphism in the promoter region of LncRNA GAS5 and cancer risk: A meta-analysis of 7005 cases and 8576 controls. Meta Gene 2018;18:177-83. [DOI: 10.1016/j.mgene.2018.09.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Zou H, Zhou HH. WITHDRAWN: Single nucleotide polymorphism, a putative driver for the role of long intergeneric non-coding RNA. Cancer Lett 2018:S0304-3835(18)30691-8. [PMID: 30503557 DOI: 10.1016/j.canlet.2018.11.025] [Reference Citation Analysis]
56 Tang Y, Wang Y, Wang X, Liu Y, Zheng K. A Genetic Variant of rs145204276 in the Promoter Region of Long Noncoding RNA GAS5 Is Associated With a Reduced Risk of Breast Cancer. Clin Breast Cancer 2019;19:e415-21. [PMID: 30846409 DOI: 10.1016/j.clbc.2018.11.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
57 Aminian K, Mashayekhi F, Mirzanejad L, Salehi Z. A functional genetic variant in GAS5 lncRNA (rs145204276) modulates p27Kip1 expression and confers risk for gastric cancer. Br J Biomed Sci 2019;76:83-5. [PMID: 30269656 DOI: 10.1080/09674845.2018.1530581] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
58 Zhu L, Zhu Q, Wen H, Huang X, Zheng G. Mutations in GAS5 affect the transformation from benign prostate proliferation to aggressive prostate cancer by affecting the transcription efficiency of GAS5. J Cell Physiol 2019;234:8928-40. [PMID: 30317620 DOI: 10.1002/jcp.27561] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
59 Toraih EA, Alghamdi SA, El-Wazir A, Hosny MM, Hussein MH, Khashana MS, Fawzy MS. Dual biomarkers long non-coding RNA GAS5 and microRNA-34a co-expression signature in common solid tumors. PLoS One 2018;13:e0198231. [PMID: 30289954 DOI: 10.1371/journal.pone.0198231] [Cited by in Crossref: 21] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
60 Zheng Z, Liu S, Wang C, Han X. A Functional Polymorphism rs145204276 in the Promoter of Long Noncoding RNA GAS5 Is Associated with an Increased Risk of Ischemic Stroke. J Stroke Cerebrovasc Dis 2018;27:3535-41. [PMID: 30197169 DOI: 10.1016/j.jstrokecerebrovasdis.2018.08.016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
61 Dousti F, Shahrisa A, Ansari H, Hajjari M, Tahmasebi Birgani Y, Mohammadiasl J, Tahmasebi Birgani M. Long non-coding RNAs expression levels in diffuse large B-cell lymphoma: An in silico analysis. Pathol Res Pract 2018;214:1462-6. [PMID: 30104077 DOI: 10.1016/j.prp.2018.08.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
62 Yuan J, Zhang N, Zheng Y, Chen YD, Liu J, Yang M. LncRNA GAS5 Indel Genetic Polymorphism Contributes to Glioma Risk Through Interfering Binding of Transcriptional Factor TFAP2A. DNA Cell Biol 2018;37:750-7. [PMID: 30074406 DOI: 10.1089/dna.2018.4215] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
63 Zhou Y, Dai W, Wang H, Pan H, Wang Q. Long non-coding RNA CASP5 promotes the malignant phenotypes of human glioblastoma multiforme. Biochem Biophys Res Commun. 2018;500:966-972. [PMID: 29715460 DOI: 10.1016/j.bbrc.2018.04.217] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
64 Li Q, Ma G, Sun S, Xu Y, Wang B. Polymorphism in the promoter region of lncRNA GAS5 is functionally associated with the risk of gastric cancer. Clin Res Hepatol Gastroenterol 2018;42:478-82. [PMID: 29602737 DOI: 10.1016/j.clinre.2018.01.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
65 Xu L, Xia C, Xue B, Sheng F, Xiong J, Wang S. A promoter variant of lncRNA GAS5 is functionally associated with the development of osteosarcoma. J Bone Oncol 2018;12:23-6. [PMID: 30013899 DOI: 10.1016/j.jbo.2018.03.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
66 Li Y, Jing F, Ding Y, He Q, Zhong Y, Fan C. Long noncoding RNA CCAT1 polymorphisms are associated with the risk of colorectal cancer. Cancer Genet 2018;222-223:13-9. [PMID: 29666003 DOI: 10.1016/j.cancergen.2018.02.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
67 Zheng Y, Song D, Xiao K, Yang C, Ding Y, Deng W, Tong S. LncRNA GAS5 contributes to lymphatic metastasis in colorectal cancer. Oncotarget. 2016;7:83727-83734. [PMID: 27863421 DOI: 10.18632/oncotarget.13384] [Cited by in Crossref: 49] [Cited by in F6Publishing: 56] [Article Influence: 12.3] [Reference Citation Analysis]
68 Ding L, Wang M, Sun D, Li A. TPGLDA: Novel prediction of associations between lncRNAs and diseases via lncRNA-disease-gene tripartite graph. Sci Rep 2018;8:1065. [PMID: 29348552 DOI: 10.1038/s41598-018-19357-3] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 12.0] [Reference Citation Analysis]
69 Li S, Hua Y, Jin J, Wang H, Du M, Zhu L, Chu H, Zhang Z, Wang M. Association of genetic variants in lncRNA H19 with risk of colorectal cancer in a Chinese population. Oncotarget 2016;7:25470-7. [PMID: 27027436 DOI: 10.18632/oncotarget.8330] [Cited by in Crossref: 49] [Cited by in F6Publishing: 64] [Article Influence: 12.3] [Reference Citation Analysis]
70 Duan F, Jiang J, Song C, Wang P, Ye H, Dai L, Zhang J, Wang K. Functional long non-coding RNAs associated with gastric cancer susceptibility and evaluation of the epidemiological efficacy in a central Chinese population. Gene 2018;646:227-33. [PMID: 29305976 DOI: 10.1016/j.gene.2017.12.063] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
71 Yin Z, Guo Y, Zhang J, Zhang Q, Li L, Wang S, Wang C, He Y, Zhu S, Li C, Zhang S, Zha L, Cai J, Luo B, Gao Y. Association between an indel polymorphism in the 3′UTR of COL1A2 and the risk of sudden cardiac death in Chinese populations. Legal Medicine 2017;28:22-6. [DOI: 10.1016/j.legalmed.2017.07.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
72 Hu P, Qiao O, Wang J, Li J, Jin H, Li Z, Jin Y. rs1859168 A > C polymorphism regulates HOTTIP expression and reduces risk of pancreatic cancer in a Chinese population. World J Surg Oncol. 2017;15:155. [PMID: 28818070 DOI: 10.1186/s12957-017-1218-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
73 Zhou W, Zhao Z, Wang R, Han Y, Wang C, Yang F, Han Y, Liang H, Qi L, Wang C, Guo Z, Gu Y. Identification of driver copy number alterations in diverse cancer types and application in drug repositioning. Mol Oncol 2017;11:1459-74. [PMID: 28719033 DOI: 10.1002/1878-0261.12112] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
74 Li W, Huang K, Wen F, Cui G, Guo H, Zhao S. Genetic variation of lncRNA GAS5 contributes to the development of lung cancer. Oncotarget 2017;8:91025-9. [PMID: 29207621 DOI: 10.18632/oncotarget.19955] [Cited by in Crossref: 15] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
75 Rong H, Gu S, Zhang G, Kang L, Yang M, Zhang J, Shen X, Guan H. MiR-2964a-5p binding site SNP regulates ATM expression contributing to age-related cataract risk. Oncotarget 2017;8:84945-57. [PMID: 29156695 DOI: 10.18632/oncotarget.17600] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
76 Rao AKDM, Rajkumar T, Mani S. Perspectives of long non-coding RNAs in cancer. Mol Biol Rep 2017;44:203-18. [PMID: 28391434 DOI: 10.1007/s11033-017-4103-6] [Cited by in Crossref: 53] [Cited by in F6Publishing: 66] [Article Influence: 10.6] [Reference Citation Analysis]
77 Zhang ZL, Zhao LJ, Chai L, Zhou SH, Wang F, Wei Y, Xu YP, Zhao P. Seven LncRNA-mRNA based risk score predicts the survival of head and neck squamous cell carcinoma. Sci Rep 2017;7:309. [PMID: 28331188 DOI: 10.1038/s41598-017-00252-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
78 Yan H, Zhang D, Li X, Yuan X, Yang Y, Zhu K, Zeng H, Li X, Cao S, Zhou H, Zhang W, Chen X. Long non-coding RNA GAS5 polymorphism predicts a poor prognosis of acute myeloid leukemia in Chinese patients via affecting hematopoietic reconstitution. Leukemia & Lymphoma 2016;58:1948-57. [DOI: 10.1080/10428194.2016.1266626] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
79 Wang S, Zhang Z, Yang Y, Wang C, Tao R, Hu S, Yin Z, Zhang Q, Li L, He Y, Zhu S, Li C, Zhang S, Zhang J, Sheng L, Wu F, Luo B, Gao Y. An insertion/deletion polymorphism within 3'UTR of RYR2 modulates sudden unexplained death risk in Chinese populations. Forensic Sci Int 2017;270:165-72. [PMID: 27987400 DOI: 10.1016/j.forsciint.2016.12.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
80 Schmitt AM, Chang HY. Long Noncoding RNAs in Cancer Pathways. Cancer Cell. 2016;29:452-463. [PMID: 27070700 DOI: 10.1016/j.ccell.2016.03.010] [Cited by in Crossref: 1455] [Cited by in F6Publishing: 1820] [Article Influence: 242.5] [Reference Citation Analysis]
81 Qian X, Xu C, Zhao P, Qi Z. Long non-coding RNA GAS5 inhibited hepatitis C virus replication by binding viral NS3 protein. Virology. 2016;492:155-165. [PMID: 26945984 DOI: 10.1016/j.virol.2016.02.020] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 6.5] [Reference Citation Analysis]
82 Gong J, Tian J, Lou J, Ke J, Li L, Li J, Yang Y, Gong Y, Zhu Y, Zhang Y, Zhong R, Chang J, Miao X. A functional polymorphism in lnc-LAMC2-1:1 confers risk of colorectal cancer by affecting miRNA binding. CARCIN 2016;37:443-51. [DOI: 10.1093/carcin/bgw024] [Cited by in Crossref: 49] [Cited by in F6Publishing: 57] [Article Influence: 8.2] [Reference Citation Analysis]
83 Wang J, Ma R, Ma W, Chen J, Yang J, Xi Y, Cui Q. LncDisease: a sequence based bioinformatics tool for predicting lncRNA-disease associations. Nucleic Acids Res 2016;44:e90. [PMID: 26887819 DOI: 10.1093/nar/gkw093] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 8.3] [Reference Citation Analysis]
84 Wajnberg G, Passetti F. Using high-throughput sequencing transcriptome data for INDEL detection: challenges for cancer drug discovery. Expert Opin Drug Discov 2016;11:257-68. [PMID: 26787005 DOI: 10.1517/17460441.2016.1143813] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]